Cellectar Biosciences Inc (CLRB)
3.33
-0.09
(-2.63%)
USD |
NASDAQ |
May 06, 16:00
3.33
0.00 (0.00%)
After-Hours: 07:28
Cellectar Biosciences Shareholders Equity (Quarterly): -1.356M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.356M |
September 30, 2023 | -13.35M |
June 30, 2023 | -0.467M |
March 31, 2023 | 7.334M |
December 31, 2022 | 15.51M |
September 30, 2022 | 12.75M |
June 30, 2022 | 20.19M |
March 31, 2022 | 27.21M |
December 31, 2021 | 33.05M |
September 30, 2021 | 38.59M |
June 30, 2021 | 43.98M |
March 31, 2021 | 49.78M |
December 31, 2020 | 54.79M |
September 30, 2020 | 16.22M |
June 30, 2020 | 19.99M |
March 31, 2020 | 5.246M |
December 31, 2019 | 9.059M |
September 30, 2019 | 12.23M |
June 30, 2019 | 15.99M |
March 31, 2019 | 9.847M |
December 31, 2018 | 13.26M |
September 30, 2018 | 16.88M |
June 30, 2018 | 4.707M |
March 31, 2018 | 7.452M |
December 31, 2017 | 10.75M |
Date | Value |
---|---|
September 30, 2017 | 7.593M |
June 30, 2017 | 10.86M |
March 31, 2017 | 13.75M |
December 31, 2016 | 13.54M |
September 30, 2016 | 7.717M |
June 30, 2016 | 9.829M |
March 31, 2016 | 2.577M |
December 31, 2015 | 1.650M |
September 30, 2015 | 0.6802M |
June 30, 2015 | 2.373M |
March 31, 2015 | 4.588M |
December 31, 2014 | 6.698M |
September 30, 2014 | 13.15M |
June 30, 2014 | -2.541M |
March 31, 2014 | -0.7273M |
December 31, 2013 | 1.700M |
September 30, 2013 | 4.426M |
June 30, 2013 | 5.444M |
March 31, 2013 | 7.130M |
December 31, 2012 | 10.16M |
September 30, 2012 | 9.067M |
June 30, 2012 | 10.63M |
March 31, 2012 | 7.561M |
December 31, 2011 | 9.481M |
September 30, 2011 | 5.897M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-13.35M
Minimum
Sep 2023
54.79M
Maximum
Dec 2020
19.30M
Average
15.99M
Median
Jun 2019
Shareholders Equity (Quarterly) Benchmarks
Perspective Therapeutics Inc | 75.18M |
Eli Lilly and Co | 12.81B |
Actinium Pharmaceuticals Inc | 43.86M |
Bristol-Myers Squibb Co | 16.49B |
Altimmune Inc | 194.10M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 12.08M |
Total Liabilities (Quarterly) | 13.43M |